Adipose-derived mesenchymal stem cells for treatment of complex perianal fistula
The aim of this study is to assess the efficacy and safety of autologous adipose-derived mesenchymal stem cells (MSCs) for the treatment of complex perianal fistulas in patients without inflammatory bowel disease (e.g., Crohn's disease).
Read More
Product Information for
Adipose-derived mesenchymal stem cells for treatment of complex perianal fistula